TTK Healthcare Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Jun 2026 is 13.75% vs 8.91% in Jun 2025

Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is 63.69% vs -58.83% in Jun 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 450.00% vs -61.16% in Jun 2025

Interest

YoY Growth in quarter ended Jun 2026 is -31.17% vs -10.47% in Jun 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of TTK Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

257.56

742.13

-484.57

-65.29%

Other Operating Income

0.00

Total Operating income

257.56

742.13

-484.57

-65.29%

Raw Material Cost

61.23

492.38

-431.15

-87.56%

Purchase of Finished goods

55.13

4.38

50.75

1,158.68%

(Increase) / Decrease In Stocks

-2.17

-15.56

13.39

86.05%

Employee Cost

46.61

69.56

-22.95

-32.99%

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

-0.01

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

82.02

94.99

-12.97

-13.65%

Total Expenditure (Excl Depreciation)

242.82

645.76

-402.94

-62.40%

Operating Profit (PBDIT) excl Other Income

14.74

96.37

-81.63

-84.70%

Other Income

16.79

10.41

6.38

61.29%

Operating Profit (PBDIT)

31.53

106.78

-75.25

-70.47%

Interest

0.53

10.98

-10.45

-95.17%

Exceptional Items

0.00

Gross Profit (PBDT)

31.00

95.80

-64.80

-67.64%

Depreciation

2.14

16.68

-14.54

-87.17%

Profit Before Tax

28.86

79.12

-50.26

-63.52%

Tax

7.58

21.46

-13.88

-64.68%

Provisions and contingencies

0.00

Profit After Tax

21.28

57.66

-36.38

-63.09%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

21.28

57.66

-36.38

-63.09%

Equity Capital

14.13

171.00

-156.87

-91.74%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

15.06

3.37

11.69

346.88%

Diluted Earnings per share

15.06

3.37

11.69

346.88%

Operating Profit Margin (Excl OI)

5.72%

12.99%

0.00

-7.27%

Gross Profit Margin

12.04%

12.91%

0.00

-0.87%

PAT Margin

8.26%

7.77%

0.00

0.49%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 257.56 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 18.16% vs 4.15% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 13.75% vs 8.91% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 21.28 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -2.21% vs 106.65% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 63.69% vs -58.83% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 14.74 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 33.64% vs 54.48% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 450.00% vs -61.16% in Jun 2025

Quarterly - Interest

Interest 0.53 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -17.19% vs -5.88% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -31.17% vs -10.47% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 5.72%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025